Medinice S.A.

Warsaw Stock Exchange ICE.WA

Medinice S.A. Revenue for the year ending December 31, 2023: USD 57.06 K

Medinice S.A. Revenue is USD 57.06 K for the year ending December 31, 2023, a 1.62% change year over year. Revenue is the total amount of money generated from the sales of goods or services by a company during a specific period.

Medinice S.A. Revenue for the year ending December 31, 2022 was USD 56.15 K, a -21.19% change year over year.
Medinice S.A. Revenue for the year ending December 31, 2021 was USD 71.25 K, a -28.47% change year over year.
Medinice S.A. Revenue for the year ending December 31, 2020 was USD 99.60 K, a 130.24% change year over year.
Medinice S.A. Revenue for the year ending December 31, 2019 was USD 43.26 K, a 14,498.36% change year over year.

Key data

Date	Revenue	Gross Profit	Operating Income	EBIT

Warsaw Stock Exchange: ICE.WA

Medinice S.A.

CEO	Mr. Sanjeev Choudhary
IPO Date	Sept. 1, 2018
Location	Poland
Headquarters	ul. Chmielna 132/134
Employees	16
Sector	Health Care
Industries Medical Instruments Biotechnology Pharmaceuticals

Description

Medinice S.A. provides medical solution for cardiology and cardiac surgery. The company support scientists for product commercialization including prototyping, clinical trials and certification, and product sales. Medinice S.A. was founded in 2012 and is based in Warsaw, Poland.

Key trends

Past 5 years